Qi Chen

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Shoujie Huang, Xuefeng Zhang, Yingying Su et al. · The Lancet · 2024 · 57 citations

Vaccination, Long-term Efficacy, Viral Hepatitis +5

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

Fengcai Zhu, Guo‐Hua Zhong, Weijin Huang et al. · The Lancet Infectious Diseases · 2023 · 37 citations

Vaccination, Vaccinology, Vaccine Safety +11

A biodegradable antibiotic-eluting PLGA nanofiber-loaded deproteinized bone for treatment of infected rabbit bone defects

Jianting Gao, Guofeng Huang, Guojun Liu et al. · Journal of Biomaterials Applications · 2016 · 30 citations

Tissue Engineering, Engineering, Biomaterials Design +16

Inflammation-restricted anti-inflammatory activities of a N -acylethanolamine acid amidase (NAAA) inhibitor F215

Yuhang Li, Pan Zhou, Hui-Xia Chen et al. · Pharmacological Research · 2018 · 26 citations

Inflammation, Anti-inflammatory, Biochemistry +9

Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

Yuemei Hu, Zhaofeng Bi, Ya Zheng et al. · Science Bulletin · 2023 · 23 citations · Full text

Immunodeficiencies, Immunology, Bivalent Vaccine +23